Allergan Korea names new CEO

Published: 2011-09-08 06:56:00

Updated: 2011-09-08 06:56:00

Allergan Korea said it has named Stephene Nardo, Allergan’s ex-general manager of pharmaceutical marketing in Asia-Pacific region, to replace Patrick Holt, as of August 16.

Nardo served as director of GlaxoSmithKline’s respiratory business in Asia-Pacific region for 20 years.

Industry watch...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK